Dr. Miller’s Textbooks and Reports

Dr. Miller has authored and/or contributed to dozens of textbooks and reports. Below is a list. Ask us if one of them can help explain your particular condition and we will be happy to share the full text.

1. Schrier RW, Miller PD. Water metabolism in diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion. In: Kurtzman N, Martinez-Maldonado M, eds.Renal Pathophysiology. Taylor-Brown Publishers; 1976.

2. Schrier RW, Miller PD, Lacher JW. Diuretics and hyponatremia. International Symposium on Diuretics.Switzerland: Bockringer Mannhum; 1977:183-192.

3. Linas SL, Anderson RJ, Miller PD, Schrier RW.Rational use of diuretics in cirrhosis.In: Epstein M, ed. The Kidney in Liver Disease. New York, NY: Elsevier; 1978:313-331.

4. Miller PD. Osteoporosis and other metabolic bone diseases.In: Schrier RW, ed.Geriatric Medicine: The Care of the Elderly Patient. 2nd ed. Philadelphia, PA: WB Saunders Co; 1990:324-340.

5. Miller PD. Clinical interpretation and utility of bone densitometry.Osteoporosis in Clinical Medicine.In: Rosen CJ, ed.Totowa, NJ: Humana Press, Inc; 1996:113-119.

6. Miller PD. Bone mass in renal disease.Osteoporosis in Clinical Medicine.In: Rosen CJ, ed. Totowa, NJ: Humana Press, Inc; 1996:171-174.

7. Miller PD. Diagnostic prediction of increased risk of hip fracture:a clinician’s perspective.In: Ringe J, ed. Hip Fractures. Stuttgart, Germany: Georg Thieme Verlag; 1996:53-62.

8. Miller PD. Osteoporosis in the elderly.In: Jahnigen D, Schrier RW, eds.Geriatric Medicine.2nd ed. Cambridge, MA: Blackwell Science, Co; 1996:534-557.

9. Miller PD, Harris ST.Clinical application of bone densitometry. In: Genant HK, Guglielmi G, Jergas M, eds.Bone Densitometry and Osteoporosis.Berlin, Heidelberg, Germany: Springer-Verlag; 1998:477-487.

10. Avecilla LS, Miller PD. Normal reference data. In: Njeh CF, FuerstHD, Glüer C-C, Genant HK, eds.Quantitative Ultrasound: Assessment of Osteoporosis and Bone Status. London, UK: Martin Dunitz, Ltd; 1999:221-243.

11. Miller PD. Osteoporosis associated with systemic illness and medications. In: Marcus R, ed. Atlas of Clinical Endocrinology.Philadelphia, PA: Current Medicine Group; 2000.

12. Miller PD, Bonnick SL. Clinical application of bone densitometry.In: Favus MJ, ed.Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 1999:152-159.

13. Sterkel BB, Miller PD. Bone mass measurement techniques in clinical practice.In: Avioli LV, ed. The Osteoporotic Syndrome: Detection, Prevention, and Treatment. 4thed.San Diego, CA:Academic Press; 2000:45-66.

14. Miller PD, Zapalowski C. Bone mineral density measurements. In: Henderson JE, Goltzman D, eds.The Osteoporosis Primer. Cambridge, UK: Cambridge UP; 2000:262-276.

15. Masad T, Miller PD. Bone densitometry in the elderly.In: Fordham JN, ed.Manual of Bone Densitometry Measurements: an Aid to the Interpretation of Bone Densitometry Measurements in a Clinical Setting.London, UK: Springer-Verlag; 2000:199-219.

16. Miller PD. Controversial issues in bone densitometry.In: Bilezikian JP, Raisz LG, Rodan GA, eds.Principles of Bone Biology.San Diego, CA: Academic Press; 2002:1587-1597.

17. Miller PD. Osteoporosis.In:Rakel RE, Bope ET, eds.Conn’s Current Therapy. Philadelphia, PA: WB Saunders Co;2002:586-598.

18. Miller PD. Paget’s disease.In: Rakel RE, Bope ET, eds.Conn’s Current Therapy. Philadelphia, PA: WB Saunders Co; 2002:598-600.

19. Miller PD. Osteoporosis associated with systemic illness and medications. In: Orwoll ES, ed. Atlas of Osteoporosis. Philadelphia, PA: Current Medicine Group; 2003:119-136.

20. Miller PD.The clinical application of gender-based databases for the diagnosis of osteoporosis and fracture risk prediction.In: Legato MJ, Bilezikian JP, eds.Principles of Gender-specific Medicine.New York, NY: Gulf Professional Publishing (Elsevier); 2004:1033-1042.

21. Miller PD.Risk factors for osteoporotic fractures.In: McDermott MT, Zapalowski C, Miller PD, eds.OsteoporosisHot Topics. Philadelphia, PA: Hanley & Belfus; 2004:15-24.

22. Miller PD. Diagnosis of osteoporosis. In: McDermott MT, Zapalowski C, Miller PD, eds.Osteoporosis Hot Topics. Philadelphia, PA: Hanley & Belfus; 2004:25-34.

23. McDermott MT, Zapalowski C, Miller PD. Treatment of osteoporosis: pharmacologic.In: McDermott MT, Zapalowski C, Miller PD, eds.OsteoporosisHot Topics. Philadelphia, PA: Hanley & Belfus; 2004:71-109.

24. Miller PD. Monitoring osteoporosis therapy.In: McDermott MT, Zapalowski C, Miller PD, eds.OsteoporosisHot Topics. Philadelphia, PA: Hanley & Belfus; 2004:111-121.

25. Miller PD. Bone mass measurement.In: Martini L, ed. Encyclopedia of Endocrine Diseases.New York, NY: Elsevier; 2004:378-385.

26. Miller PD, Shane E.Management of transplantation renal bone disease: interplay of bone mineral density and decisions regarding bisphosphonate use.In: Weir MR, ed.Medical Management of Kidney Transplantation.Philadelphia, PA: Lippincott Williams & Wilkins; 2004:359-375.

27. Miller PD, Lerma EV. Renal bone diseases.In: Kleerekoper M, Siris ES, McClung M, eds.The Bone and Mineral Manuel: A Practical Guide. 2nd ed. Burlington, MA:Elsevier Academic Press;2005:;127-137.

28. Miller PD. Renal osteodystrophy. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4th ed.London, UK: Elsevier;2005.

29. Miller PD, Huffer W. Renal osteodystrophy. In:Schrier RW, Cohen AH, eds.Essential Atlas of Nephrology & hypertension. 2nd ed. Philadelphia, PA: Current Medicine Group; 2006;261-276.

30. Miller PD, Leonard M. Clinical application of bone mass measurements. In:Favus MJ. Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism. 6th ed. Philadelphia, PA: LippincottWilliams &Wilkins; 2006.

31. Miller PD. Combination therapy for osteoporosis: what do the data tell us? In: Lane NE, Sambrook P, eds.Osteoporosis and the Osteoporosis of Rheumatic Diseases. Philadelphia, PA: Mosby/Elsevier; 2006:192-202.

32. Kanis JA on behalf of the World Health Organization Scientific Group (2007). Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases. Sheffield, UK: University of Sheffield; 2007. Available at: https://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf. Accessed January 23, 2017. [Dr Miller was a member of the Group.]

33. Miller PD. Paget’s disease of bone. In: Rakel RE, Bope ET, eds.Conn’s Current Therapy. Philadelphia, PA: Saunders/Elsevier; 2007:718-721.

34. Camacho PM, Miller PD. Osteoporosis: A Guide for Clinicians. Philadelphia, PA: Lippincott Williams &Wilkins; 2007.

35. Miller PD. Bisphosphonates: pharmacology and use in the treatment of osteoporosis. In: Marcus R, Feldman D, Nelson D, Rosen CJ. Osteoporosis. 3rd ed. San Diego, CA: Elsevier Academic Press; 2007:1725-1736.

36. Faulkner KG, Miller PD. Clinical use of bone densitometry. In: Marcus R, Feldman D, Nelson D, Rosen CJ. Osteoporosis. 3rd ed. San Diego, CA: Elsevier Academic Press; 2007:1493-1515.

37. Miller PD. Renal bone diseases.In: Orwoll E, ed.Atlas of Metabolic Bone Diseases.3rd ed.New York, NY: Springer; 2008:135-146.

38. Miller PD. Osteoporosis in men with impaired renal function. In: Orwoll ES, Bilezikian JP, Vanderschueren D. Osteoporosis in Men. 2nd ed. San Diego, CA: Academic Press/Elsevier; 2010:453-464.

39. Miller PD. Renal osteodystrophy. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds.Rheumatology. 5th ed. Philadelphia, PA: Mosby/Elsevier; 2010:2013-2019.

40. Miller PD. Rickets, osteomalacia, and renal osteodystrophy. In: Iannotti JP, Parker RD, eds.The Netter Collection of Medical Illustrations, vol 6. Philadelphia, PA: Saunders/Elsevier; 2012:3(13)-3(16).

41. Miller PD. Diseases of mineral metabolism and bone: emerging therapeutics for postmenopausal osteoporosis. In: Bronner F, Farach-Carson MC, Roach HI, eds. Bone—Metabolic Functions and Modulators. London, UK: Springer-Verlag; 2012:147-162.

42. Bonnick SL, Miller PD. Clinical use of bone densitometry. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, eds. Osteoporosis. 4th ed. Waltham, MA: Academic Press/Elsevier; 2013:1551-1568.

43. Diab DL,Watts NB, Miller PD. Bisphosphonates: pharmacology and use in the treatment of osteoporosis.In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, eds. Osteoporosis. 4th ed. Academic Press/Elsevier: Waltham, MA;2013:1859-1872.

44. Miller PD, Watts NB. Bisphosphonates. In: Stovall DW, ed.Osteoporosis: Diagnosis and Management. Oxford, UK: John Wiley & Sons; 2013:123-143.

45. Miller PD, Jamal S, Sprague SM. Clinical skeletal syndromes associated with parathyroid disorders in chronic kidney disease. In: Bilezikian JP, Marcus R, Levine MA, Marcocci C, Silverberg SJ, Potts JT Jr. The Parathyroids: Basic and Clinical Concepts. 3rd ed. Waltham, MA: Academic Press/Elsevier; 2014:653-669.

46. Cosman F

47. Miller PD. Renal osteodystrophy. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology.6th ed. Philadelphia, PA: Elsevier Mosby; 2014:1692-1697.

48. Miller PD. Osteoporosis in patients with chronic kidney disease: diagnosis, evaluation, and management. UpToDate 2020. Available at: http://www.uptodate.com/contents/osteoporosis-in-patients-with-chronic-kidney-disease-diagnosis-evaluation-and-management Last updated January 2020

49. Miller, P. D., Bilezikian, J. P., Lewiecki, E. M., Watts, N. B. and Carey, J. J. (2018), Re: A History of Pivotal Advances in Clinical Research Into Bone and Mineral Diseases. J Bone Miner Res, 33: 1900-1901. doi:10.1002/jbmr.3566

50. Dima L, Watts NB, Miller PD. Bisphosphonates pharmacology and use in the treatment of osteoporosis. In: Osteoporosis. Elsevier. 2020; Editor: Dempster D. :Chapter

51. Lewiecki EM, Miller PD, Watts NB. Standard Techniques of Bone Mass Measurements in Adults. In : Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2020. Eds: Bilezikian JP et al. Chapt